23
January
0
Comments
Gossamer Bio Seeks $230M IPO Amid Government Shutdown
in Legal News
Law360 (January 23, 2019, 9:20 PM EST) — Biotechnology firm Gossamer Bio Inc. on Wednesday disclosed pricing details for a $230 million initial public offering, using an unconventional route that allows companies to go public without the usual green…
